The Food and Drug Administration’s Center for Devices and Radiological Health has released its regulatory science priorities for fiscal year 2017, which starts on October 1, with a heavy emphasis on health information technology.

The document from FDA’s Center for Devices and Radiological Health (CDRH)—which is responsible for assuring the safety, effectiveness, performance and quality of medical devices and radiation-emitting products used to treat, prevent, and diagnose disease—lays out its top regulatory science priorities for FY17.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access